Xiang-Qun (Sean) Xie, EMBA, PhD, was awarded a $5.4 million NIH center grant to establish a National Institute of Drug Abuse (NIDA) Center of Excellence for Computational Chemogenomics Drug Abuse Research.
Xie serves as the director for this joint initiative between the University of Pittsburgh and Carnegie Mellon University, with goals to advance and implement state-of-the-art computational chemical genomics, computational biology and computational genomics technologies for facilitating research on drug abuse prevention and treatment; to centralize the big data chemical genomics knowledgebase and computational program tools through a GPU-accelerated cloud computing server platform and thus enable efficient information exchange; and to advance neurological systems pharmacology and translational research and to accelerate the development of novel intervention strategies for preventing and treating drug abuse and addiction.
Xie is the associate dean for research innovation and director of Computational Chemical Genomics Screening Center at the School of Pharmacy.
